Bought
Maintained
Sold
Other funds holding PMC
UBS's PMC Position: Q3 2014 in Review
UBS increased its PharMerica (PMC) stake by 28% in Q3 2014, buying an estimated $676K and bringing the position to 118,083 shares worth $2.88M. The position accounts for ﹤0.01% of the portfolio, ranked #2569.
UBS first reported a position in PMC in Q2 2013 and has held it in 6 quarters since. 161 funds tracked by Wall St. Rank hold PMC as of Q3 2014.
- UBS held 118,083 shares of PharMerica worth $2.88M as of Q3 2014.
- UBS bought 25,476 PharMerica shares in Q3 2014, an estimated $676K.
- PharMerica made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2569 holding.
- UBS first reported a position in PharMerica in Q2 2013 and has held it in 6 quarters since.
- 161 funds tracked by Wall St. Rank held PharMerica as of Q3 2014.
Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.